Cutera (NASDAQ: CUTR) is one of 46 publicly-traded companies in the “Electromedical equipment” industry, but how does it weigh in compared to its rivals? We will compare Cutera to related companies based on the strength of its analyst recommendations, earnings, risk, institutional ownership, profitability, dividends and valuation.
This table compares Cutera and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
97.2% of Cutera shares are held by institutional investors. Comparatively, 40.7% of shares of all “Electromedical equipment” companies are held by institutional investors. 11.6% of Cutera shares are held by company insiders. Comparatively, 20.2% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This is a summary of recent ratings and recommmendations for Cutera and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Cutera currently has a consensus target price of $45.40, suggesting a potential downside of 10.89%. As a group, “Electromedical equipment” companies have a potential upside of 19.06%. Given Cutera’s rivals higher probable upside, analysts clearly believe Cutera has less favorable growth aspects than its rivals.
Risk and Volatility
Cutera has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500. Comparatively, Cutera’s rivals have a beta of 1.58, meaning that their average share price is 58% more volatile than the S&P 500.
Valuation and Earnings
This table compares Cutera and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Cutera||$151.49 million||$29.99 million||66.17|
|Cutera Competitors||$1.10 billion||$121.87 million||-38.54|
Cutera’s rivals have higher revenue and earnings than Cutera. Cutera is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Cutera rivals beat Cutera on 7 of the 13 factors compared.
Cutera Company Profile
Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; solera console platform, including Opus and Titan consoles; and CoolGlide systems, as well as provides myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; skin care products; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.